Molecule Name |
DB00180
|
DrugBank Groups |
Approved
|
Cluster No |
52
|
Smiles |
FC2(C1(=CC(=O)C=CC1(C3(C(O)CC4(C(C3(C2))CC5(OC(OC45(C(=O)CO))(C)C))(C)))C))
|
Download |
mol2, pdbqt
|
TPSA |
93,06
|
Non-H Atoms |
31
|
Non-C/H Atoms |
7
|
Metal-Atoms |
0
|
Electronegative Atoms |
7
|
Stereo Centers |
9
|
Rotatable Bonds |
2
|
Rings Closures |
5
|
Small Rings |
5
|
Aromatic Rings |
0
|
Aromatic Atoms |
0
|
sp3-Atoms |
22
|
Symmetric atoms |
1
|
cLogS |
-3,712
|
MW |
434,502
|
cLogP |
1,3033
|
HBA |
6
|
HBD |
2
|
Ro5 violations |
0
|
Druglikeness |
0,79255
|
DrugScore |
0,62740285363883
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2+
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-4,6355
|
Caco-2 Permeability 2 |
0,7629
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
0,6285
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,9646
|
Honey Bee Toxicity |
High HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
I
|
Rat Acute Toxicity (LD50, mol/kg) |
2,7033
|
Carcinogenicity (Three-class) |
Danger
|